Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine
Resource Type
Short Survey
Authors
Le, Kaixing ; Zhou, Xin ; Ibraheim, Hajir ; Anandabaskaran, Sulak ; Saifuddin, Aamir ; McFarlane, Leon R. ; Anand, Nikhil ; Constable, Laura ; Seoane, Rocio Castro ; D’Mello, Andrea ; Balarajah, Sharmili ; Hicks, Lucy C. ; Williams, Horace R.T. ; Lo, Jonathan W. ; Hart, Ailsa L. ; Altmann, Daniel M. ; Boyton, Rosemary J. ; Teare, Julian P. ; Nice, Rachel ; Bewshea, Claire ; Goodhand, James R. ; Kennedy, Nicholas A. ; Barnes, Anna ; Kirkwood, John ; Parkinson, Marian ; Gardner-Thorpe, Helen ; Lees, Charlie W. ; Jones, Gareth R. ; Covil, Kate ; Derikx, Lauranne ; Fiorentino, Francesca ; Irving, Peter M. ; Parkes, Miles ; Linger, Rachel ; Kok, Klaartje ; Lee, Irish ; Cipriano, Bessie ; Patel, Kamal V. ; Sebastian, Shaji ; Kent, Alexandra J. ; Chukwurah, Ijeoma ; Haq, Sulaimaan ; Shah, Parita ; Wilken-Smith, Stephanie ; Ramanathan, Anitha ; Patel, Mikin ; Romanczuk, Lidia ; King, Rebecca ; Domingo, Jason ; Knight, Bridget ; Shamtally, Djamila ; Mendoza, Vivien ; Sanchez, Joanne ; Stark, Hannah ; Bee, Louise ; Estember, Charmaine ; Watkins, Darcy ; Stone, Sam ; Alcalde, Beatriz Gros ; Ruocco, Giuseppe ; Baden, Manisha ; Cooke, Graham ; Kourampa, Evgenia ; Pasquale, Ciro ; Robisco-Diaz, Elena ; Bhatti, Suhaylah ; Liu, Zhigang ; Alexander, James L. ; Lin, Kathy Weitung ; Ahmad, Tariq ; Pollock, Katrina M. ; Powell, Nick
Source
In Gastroenterology February 2023 164(2):300-303
Subject
Language
ISSN
0016-5085